John E Daniel

US Patent:

7567795, Jul 28, 2009

Filed:

Oct 31, 2005

Appl. No.:

11/264647

Inventors:

Laurenn L. Champion - Marietta GA, US
John Scott Daniel - Lawrenceville GA, US

Assignee:

AT&T Mobility II LLC - Atlanta GA

International Classification:

H04M 1/66

US Classification:

455410, 455411, 4554141, 455418, 455558, 455428

Abstract:

A system and method for controlling wireless network access for stolen wireless devices is disclosed. The system creates an electronic record for devices intended for sale in retail stores. The records associated with the devices include a field that identifies the devices as unsold prior to being shipped to those stores. Upon proper purchase, the retail store automatically communicates to the wireless service provider that a device has been sold. The system updates the electronic record to show that the device has been purchased. Sold devices are allowed to access the network as normal. Attempts to use a device marked as unsold result in the call being routed to a fraud management center for verification of proper device purchase.

US Patent:

8050655, Nov 1, 2011

Filed:

Jun 5, 2009

Appl. No.:

12/479329

Inventors:

Laurenn L. Champion - Marietta GA, US
John Scott Daniel - Lawrenceville GA, US

Assignee:

AT&T Mobility II LLC - Atlanta GA

International Classification:

H04M 1/66

US Classification:

455410, 455411

Abstract:

Systems and methods for controlling wireless network access for wireless devices are disclosed. A system can create an electronic record for a device intended for sale in a retail store. The record associated with the device can include an indication that the device has not been sold, and the device can be shipped to the retail store. When the device is purchased, the retail store can communicate to the wireless service provider that the device has been sold, and the system can update the electronic record to reflect that the device has been sold. The sold device can be allowed to access a network. An attempt to use a device marked as unsold can result in the call being routed to a fraud management center for verification of proper device purchase.

US Patent:

8323701, Dec 4, 2012

Filed:

Apr 23, 2009

Appl. No.:

12/428908

Inventors:

John Daniel - Woodstock GA, US
Robert Tofe - Denver CO, US
Randall Spencer - Acworth GA, US
John Russo - Sarasota FL, US

Assignee:

Mimedx Group, Inc. - Kennesaw GA

International Classification:

A61K 35/50

US Classification:

424583, 424582, 623 2372

Abstract:

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

US Patent:

8357403, Jan 22, 2013

Filed:

Sep 8, 2008

Appl. No.:

12/206508

Inventors:

John Daniel - Kennesaw GA, US
Robert Tofe - Denver CO, US
Randall Spencer - Kennesaw GA, US
John Russo - Sarasoto FL, US

Assignee:

Mimedx Group, Inc. - Kennesaw GA

International Classification:

A61K 35/50

US Classification:

424583, 424582, 623 2372, 623915

Abstract:

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

US Patent:

8372437, Feb 12, 2013

Filed:

Aug 17, 2007

Appl. No.:

11/840728

Inventors:

John Daniel - Kennesaw GA, US

Assignee:

Mimedx Group, Inc. - Kennesaw GA

International Classification:

A61K 35/50

US Classification:

424583, 424582, 623 2372

Abstract:

A method for preparing placenta membrane tissue grafts for medical use, includes obtaining a placenta from a subject, cleaning the placenta, separating the chorion tissue from the amniotic membrane, mounting a selected layer of either the chorion tissue or the amniotic membrane onto a drying fixture, dehydrating the selected layer on the drying fixture, and cutting the selected layer into a plurality of tissue grafts. Preferably, the drying fixture includes grooves or raised edges that define the outer contours of each desired tissue graft, after they are cut, and further includes raised or indented logos that emboss the middle area of the tissue grafts during dehydration and that enables an end user to distinguish the top from the bottom side of the graft. The grafts are comprised of single layers of amnion or chorion, multiple layers of amnion or chorion, or multiple layers of a combination of amnion and chorion.

US Patent:

8372438, Feb 12, 2013

Filed:

Aug 7, 2012

Appl. No.:

13/569138

Inventors:

John Daniel - Woodstock GA, US
Robert Tofe - Denver CO, US
Randall Spencer - Acworth GA, US
John Russo - Sarasota FL, US

Assignee:

Mimedx Group, Inc. - Kennesaw GA

International Classification:

A61K 35/50

US Classification:

424583

Abstract:

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

US Patent:

8372439, Feb 12, 2013

Filed:

Aug 7, 2012

Appl. No.:

13/569140

Inventors:

John Daniel - Woodstock GA, US
Robert Tofe - Denver CO, US
Randall Spencer - Acworth GA, US
John Russo - Sarasota FL, US

Assignee:

Mimedx Group, Inc. - Kennesaw GA

International Classification:

A61K 35/50

US Classification:

424583, 424582, 623 2372

Abstract:

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

US Patent:

8409626, Apr 2, 2013

Filed:

Aug 7, 2012

Appl. No.:

13/569134

Inventors:

John Daniel - Woodstock GA, US
Robert Tofe - Denver CO, US
Randall Spencer - Acworth GA, US
John Russo - Sarasota FL, US

Assignee:

MiMedx Group, Inc. - Kennesaw GA

International Classification:

A61K 35/50

US Classification:

424583

Abstract:

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.